A detailed history of Deutsche Bank Ag\ transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 232,600 shares of ANIP stock, worth $13.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
232,600
Previous 9,816 2269.6%
Holding current value
$13.1 Million
Previous $625,000 2120.16%
% of portfolio
0.01%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$54.33 - $65.72 $12.1 Million - $14.6 Million
222,784 Added 2269.6%
232,600 $13.9 Million
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $138,130 - $162,415
2,360 Added 31.65%
9,816 $625,000
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $2,059 - $2,648
-38 Reduced 0.51%
7,456 $515,000
Q4 2023

Feb 14, 2024

SELL
$48.72 - $65.43 $7,259 - $9,749
-149 Reduced 1.95%
7,494 $413,000
Q3 2023

Nov 09, 2023

BUY
$50.28 - $64.61 $129,219 - $166,047
2,570 Added 50.66%
7,643 $443,000
Q2 2023

Aug 14, 2023

SELL
$37.29 - $53.83 $105,791 - $152,715
-2,837 Reduced 35.87%
5,073 $273,000
Q1 2023

May 15, 2023

BUY
$37.61 - $45.72 $85,487 - $103,921
2,273 Added 40.32%
7,910 $314,000
Q4 2022

Feb 13, 2023

BUY
$31.9 - $41.95 $2,679 - $3,523
84 Added 1.51%
5,637 $226,000
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $4.01 Million - $5.11 Million
-134,431 Reduced 96.03%
5,553 $178,000
Q2 2022

Aug 11, 2022

SELL
$23.09 - $33.46 $837,197 - $1.21 Million
-36,258 Reduced 20.57%
139,984 $4.15 Million
Q1 2022

May 13, 2022

SELL
$26.91 - $47.15 $1.36 Million - $2.38 Million
-50,398 Reduced 22.24%
176,242 $4.95 Million
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $1.13 Million - $1.94 Million
34,166 Added 17.75%
226,640 $10.4 Million
Q3 2021

Nov 04, 2021

BUY
$26.48 - $35.99 $1.59 Million - $2.15 Million
59,862 Added 45.14%
192,474 $6.32 Million
Q2 2021

Aug 11, 2021

BUY
$31.86 - $38.6 $488,477 - $591,815
15,332 Added 13.07%
132,612 $4.65 Million
Q1 2021

May 13, 2021

SELL
$28.4 - $36.14 $296,325 - $377,084
-10,434 Reduced 8.17%
117,280 $4.24 Million
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $44,726 - $59,415
1,888 Added 1.5%
127,714 $3.71 Million
Q3 2020

Nov 12, 2020

BUY
$26.38 - $33.1 $11,818 - $14,828
448 Added 0.36%
125,826 $3.55 Million
Q2 2020

Aug 13, 2020

BUY
$29.93 - $50.1 $43,518 - $72,845
1,454 Added 1.17%
125,378 $4.06 Million
Q1 2020

May 14, 2020

BUY
$30.35 - $67.14 $294,182 - $650,788
9,693 Added 8.49%
123,924 $5.05 Million
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $16.7 Million - $23.9 Million
-299,479 Reduced 72.39%
114,231 $7.04 Million
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $6.25 Million - $8.24 Million
96,547 Added 30.44%
413,710 $30.1 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $6.57 Million - $7.96 Million
96,892 Added 43.99%
317,163 $26.1 Million
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $4.89 Million - $7.53 Million
106,680 Added 93.92%
220,271 $15.5 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $2.18 Million - $2.98 Million
-52,872 Reduced 31.76%
113,591 $5.11 Million
Q3 2018

Dec 21, 2021

BUY
$52.95 - $71.34 $376,633 - $507,441
7,113 Added 4.46%
166,463 $9.41 Million
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $1.81 Million - $2.43 Million
-34,113 Reduced 17.63%
159,350 $9.01 Million
Q2 2018

Apr 21, 2020

BUY
$56.38 - $68.08 $1.11 Million - $1.34 Million
19,706 Added 11.34%
193,463 $12.9 Million
Q2 2018

Aug 14, 2018

SELL
$56.38 - $68.08 $471,562 - $569,421
-8,364 Reduced 4.59%
173,757 $11.6 Million
Q1 2018

Oct 18, 2019

BUY
$56.98 - $72.41 $1.3 Million - $1.65 Million
22,735 Added 14.26%
182,121 $10.6 Million
Q1 2018

May 15, 2018

SELL
$56.98 - $72.41 $32,535 - $41,346
-571 Reduced 0.36%
159,386 $9.28 Million
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $585,340 - $818,817
10,982 Added 7.37%
159,957 $10.3 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $6.47 Million - $7.82 Million
148,975
148,975 $7.82 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.